Xconomy
JANUARY 24, 2017
Indianapolis-based Anthem (NYSE: ANTM ) has disclosed its coverage policy for nusinersen, the SMA drug from Biogen (NASDAQ: BIIB ) and Ionis Pharmaceuticals (NASDAQ: IONS ). Anthem said the drug is only “medically necessary” for patients with Type 1 SMA. Those are patients diagnosed with the disease within six months of birth who.
Xconomy
SEPTEMBER 7, 2017
Call him an optimist if you must, but San Diego Venture Group president Mike Krenn says venture financings for San Diego’s early stage tech startups are on a tear. “I A breakout of regional deal flow so far this year indicates that venture activity in San Diego. That is an insane data point.”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xconomy
FEBRUARY 2, 2017
While UHC’s policy is less restrictive than the one disclosed recently by rival insurer Anthem, UHC has nonetheless set limits and will only pay past an initial handful of doses if doctors can prove the drug is working. Another major U.S.
Both Sides of the Table
JUNE 3, 2010
Discussion: Had a long chat about PicClick , a company founded by Ryan Sit in San Diego. I don’t do advertising on my blog, but I thought it was worth mentioning Ryan in particular because he has an alternate model for doing a startup. They sponsor TWiVC. Founded by Shawn Gold (ex-MySpace CMO). Hello, Chair.
Tech Zulu Event
JUNE 28, 2012
The first-ever Silicon Beach Fest attracted more than 2,000 attendees from LA, San Francisco, San Diego, Santa Barbara, New York, Toronto, and London to celebrate LA startups and entertainment with panels, parties, pitch fests, hackathon, and beach games: volleyball, basketball and surfing lessons in Santa Monica and Venice on June 21-23, 2012.
Xconomy
JANUARY 6, 2017
This past Christmas weekend, Ana Memedovich had her best two days in more than a decade. Her 23-year-old son Mikhail has spinal muscular atrophy, or SMA, a rare genetic disease that has slowly robbed him of the ability to walk and function independently. 23, the FDA approved nusinersen (Spinraza), the first-ever drug for the disease.
Xconomy
APRIL 20, 2017
Melissa Marotta pulled no punches to get her three-year-old son C.J., who has the genetic disease spinal muscular atrophy, access to nusinersen (Spinraza), the first approved drug for his condition.
Expert insights. Personalized for you.
40 
Let's personalize your content